Literature DB >> 8567397

Expression of sulfomucins in normal mucosae, colorectal adenocarcinomas, and metastases.

Y Matsushita1, N Yamamoto, H Shirahama, S Tanaka, S Yonezawa, T Yamori, T Irimura, E Sato.   

Abstract

We have examined the expression of specific mucin antigens in tissue sections from 92 cases of colorectal carcinoma, using sulfomucin-specific monoclonal antibody (MAb) 91.9H. The expression of sulfomucins was high in normal mucosae and much lower in primary colorectal carcinoma, in metastatic lesions in lymph nodes or in liver. The intracellular localization of sulfomucins was also different among these tissues. In normal mucosae, MAb 91.9H binding was seen in the supranuclear area, presumably Golgi complexes, the luminal surface, and secretory products. In primary colorectal carcinomas and in their metastatic lesions, MAb 91.9H was preferentially localized in the cell surface and substances attached to the luminal surface of glandular structures. Analysis of the lysates of normal and tumor tissues showed that very-high-molecular-weight components contained the antigenic epitopes. The intensity of MAb 91.9H binding was lower in tumors at advanced stages than in tumors at early stages. These high-molecular-weight components were apparently reactive with MAb FH6 specific for sialyl-Le(X) (s-Le(X) structures. Histological specimens with low levels of MAb 91.9H reactivity often exhibited relatively high levels of MAb FH6 reactivity. These two mucins may have reversed expression during carcinogenesis and carcinoma progression, and this change may be related to metastatic potential.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8567397      PMCID: PMC5920631          DOI: 10.1111/j.1349-7006.1995.tb03021.x

Source DB:  PubMed          Journal:  Jpn J Cancer Res        ISSN: 0910-5050


  47 in total

Review 1.  Possible functions of tumor-associated carbohydrate antigens.

Authors:  S Hakomori
Journal:  Curr Opin Immunol       Date:  1991-10       Impact factor: 7.486

2.  Increased expression of sialyl-dimeric LeX antigen in liver metastases of human colorectal carcinoma.

Authors:  S D Hoff; Y Matsushita; D M Ota; K R Cleary; T Yamori; S Hakomori; T Irimura
Journal:  Cancer Res       Date:  1989-12-15       Impact factor: 12.701

3.  Loss of expression of blood group antigen H is associated with cellular invasion and spread of oral squamous cell carcinomas.

Authors:  M Bryne; P S Thrane; E Dabelsteen
Journal:  Cancer       Date:  1990-11-15       Impact factor: 6.860

4.  Antigenic variation in cancer metastasis: immune escape versus immune control.

Authors:  V Schirrmacher; M Fogel; E Russmann; K Bosslet; P Altevogt; L Beck
Journal:  Cancer Metastasis Rev       Date:  1982       Impact factor: 9.264

5.  Adhesion of human cancer cells to vascular endothelium mediated by a carbohydrate antigen, sialyl Lewis A.

Authors:  A Takada; K Ohmori; N Takahashi; K Tsuyuoka; A Yago; K Zenita; A Hasegawa; R Kannagi
Journal:  Biochem Biophys Res Commun       Date:  1991-09-16       Impact factor: 3.575

6.  Increased expression of sialyl Lewisx antigen correlates with poor survival in patients with colorectal carcinoma: clinicopathological and immunohistochemical study.

Authors:  S Nakamori; M Kameyama; S Imaoka; H Furukawa; O Ishikawa; Y Sasaki; T Kabuto; T Iwanaga; Y Matsushita; T Irimura
Journal:  Cancer Res       Date:  1993-08-01       Impact factor: 12.701

7.  Ulex europeus agglutinin I-reactive high molecular weight glycoproteins of adenocarcinoma of distal colon and rectum and their possible relationship with metastatic potential.

Authors:  T Irimura; D M Ota; K R Cleary
Journal:  Cancer Res       Date:  1987-02-01       Impact factor: 12.701

8.  Carcinoembryonic antigen functions as an accessory adhesion molecule mediating colon epithelial cell-collagen interactions.

Authors:  M Pignatelli; H Durbin; W F Bodmer
Journal:  Proc Natl Acad Sci U S A       Date:  1990-02       Impact factor: 11.205

9.  Sialyl-dimeric Lewis-X antigen expressed on mucin-like glycoproteins in colorectal cancer metastases.

Authors:  Y Matsushita; K R Cleary; D M Ota; S D Hoff; T Irimura
Journal:  Lab Invest       Date:  1990-12       Impact factor: 5.662

10.  Novel fucolipids accumulating in human adenocarcinoma. II. Selective isolation of hybridoma antibodies that differentially recognize mono-, di-, and trifucosylated type 2 chain.

Authors:  Y Fukushi; S Hakomori; E Nudelman; N Cochran
Journal:  J Biol Chem       Date:  1984-04-10       Impact factor: 5.157

View more
  9 in total

Review 1.  Mucins and mucosal protection in the gastrointestinal tract: new prospects for mucins in the pathology of gastrointestinal disease.

Authors:  A P Corfield; N Myerscough; R Longman; P Sylvester; S Arul; M Pignatelli
Journal:  Gut       Date:  2000-10       Impact factor: 23.059

Review 2.  Perspectives on the significance of altered glycosylation of glycoproteins in cancer.

Authors:  Y J Kim; A Varki
Journal:  Glycoconj J       Date:  1997-08       Impact factor: 2.916

3.  Malignant and other properties of human colon carcinoma cells after suppression of sulfomucin production in vitro.

Authors:  H Tsuiji; S Nakatsugawa; T Ishigaki; T Irimura
Journal:  Clin Exp Metastasis       Date:  1999-03       Impact factor: 5.150

4.  A novel sialyl Le(X) expression score as a potential prognostic tool in colorectal cancer.

Authors:  Leif Schiffmann; Fabian Schwarz; Michael Linnebacher; Friedrich Prall; Jens Pahnke; Helga Krentz; Brigitte Vollmar; Ernst Klar
Journal:  World J Surg Oncol       Date:  2012-05-23       Impact factor: 2.754

5.  The interaction of large bowel microflora with the colonic mucus barrier.

Authors:  Jeffrey P Pearson; Iain A Brownlee
Journal:  Int J Inflam       Date:  2010-10-03

6.  Expression of mucin-associated sulfo-Lea carbohydrate epitopes on human colon carcinoma cells.

Authors:  H Tsuiji; M Hayashi; D M Wynn; T Irimura
Journal:  Jpn J Cancer Res       Date:  1998-12

7.  Down-regulation of Gal 3-O-sulfotransferase-2 (Gal3ST-2) expression in human colonic non-mucinous adenocarcinoma.

Authors:  Akira Seko; Koji Nagata; Suguru Yonezawa; Katsuko Yamashita
Journal:  Jpn J Cancer Res       Date:  2002-05

Review 8.  The Interaction of the Gut Microbiota with the Mucus Barrier in Health and Disease in Human.

Authors:  Anthony P Corfield
Journal:  Microorganisms       Date:  2018-08-02

9.  Relationship between the nature of mucus and crypt multiplicity in aberrant crypt foci in the rat colon.

Authors:  K Uchida; S Kado; M Onoue; K Tohyama
Journal:  Jpn J Cancer Res       Date:  1997-09
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.